Activation of PARP-1 also leads to decreased NADPH levels because this particular PARP inhibits the glycolytic enzyme, hexokinase
In the context of SUD, such mechanisms could plausibly reduce craving and compulsive drug-seeking, aligning with preclinical work showing attenuation of substance-related reinforcement and with emerging clinical data suggesting reduced alcohol-related outcomes among GLP-1RA users (18, 35)
Semaglutide is a GLP-1 receptor agonist that reduces appetite, slows stomach emptying, and steadies post-meal glucose
And, fermentable fibers like the kind you find in oats and legumes may help encourage the release of GLP-1, the gut hormone that semaglutide mimics
October 14th, 2024: FDA reevaluates Zepbound and Mounjaro shortage list removal after legal challenge The Ozempic Lawsuit is ongoing